To subscribe to our optical e-newsletters and receive them via e-mail, click here.
Glaucomatous damage can eventually make your patient a dangerous driver. Here's how to stay on top of the situation.
Despite the best intentions of the FDA, generic versions of drugs are not always identical to their branded counterparts.
With more patients and less time, clinicians need a high-priority checklist to make sure nothing important is overlooked.
Evidence indicates that large dips in blood pressure at night correlate with progression in normal-tension glaucoma patients.
Clinical data suggests that this measurement may be a valuable indicator of risk—and how a patient will respond to medication.
Clinicians seldom look for early damage in the macula, but recent work indicates that such damage can indeed be there.
Determining the clinical value of mean vs. peak IOP—and the possible importance of IOP fluctuation—remains a challenge.
Getting your glaucoma patients to come in as recommended may be just as important as proper medication use.
Laser trabeculoplasty continues to gain favor as a reliable means to reduce intraocular pressure.
With this procedure, the toughest challenges for the surgeon often occur after the surgery.
Copyright© 2000 - 2014 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.